ADVERTISEMENT
Posted: Aug 8, 2025

Pharmacist intervention reduces emergency department visits for the same medication-related events

Patient Safety

Findings of a study published in the June 2025 issue of JAMA Internal Medicine revealed that a pharmacist-led intervention in the emergency department (ED) significantly reduced hospitalizations and ED visits related to the same medication-related event at 6 months compared with usual care.

Jen Hand

Read more
Posted: Aug 8, 2025

Study quantifies how much ID pharmacists influence antimicrobial therapy decisions

Antimicrobial Therapy

When infectious disease (ID) clinicians asked ID pharmacists questions, nearly 90% of the 1,518 “curbside” inquiries resulted in clinical management changes as recommended by the pharmacist, according to a study published online on May 15, 2025, in Clinical Infectious Diseases.

Loren Bonner

Read more
Posted: Jul 7, 2025

Communication breakdowns: A persistent threat to patient safety

Patient Safety

A systematic review published in the Annals of Internal Medicine casts a spotlight on the critical role communication plays in patient safety incidents across health care settings.

Aiya Almogaber, PharmD

Read more
Posted: Jul 7, 2025

Spironolactone or amiloride? Expanding options for managing resistant hypertension

Hypertension

Patients with resistant hypertension often fail to achieve BP control despite using multiple antihypertensive agents.

Corey Diamond, PharmD

Read more
Posted: Jul 7, 2025

Rising launch prices of cancer drugs outpace inflation despite policy changes

Drug Prices

A study published in JAMA highlights a persistent trend in the rising costs of self-administered anticancer drugs—even after the passage of key policy reforms intended to curb Medicare drug spending.

Aiya Almogaber, PharmD

Read more
245678910Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT